{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:11:41Z","timestamp":1787008301034,"version":"build-2736575974"},"reference-count":36,"publisher":"China Science Publishing & Media Ltd.","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670194"],"award-info":[{"award-number":["81670194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81529001"],"award-info":[{"award-number":["81529001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603270"],"award-info":[{"award-number":["81603270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science & Technology","award":["2018ZX09711002"],"award-info":[{"award-number":["2018ZX09711002"]}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.1093\/abbs\/gmaa009","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T07:10:34Z","timestamp":1581577834000},"page":"401-410","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":7,"title":["Novel cyclophosphamide of natural products osalmide and pterostilbene induces cytotoxicity and cell cycle arrest in diffuse large B-cell lymphoma cells"],"prefix":"10.3724","volume":"52","author":[{"given":"Mengyu","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangning","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gege","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaikang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"null","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12943-015-0474-2","volume":"14","author":"Camicia R","year":"2015","unstructured":"Camicia R, Winkler HC, Hassa PO. Novel drug targets for personalized precision medicine in relapsed\/refractory diffuse large B-cell lymphoma: a comprehensive review. Mol Cancer, 2015, 14:","journal-title":"Mol Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-3-319-13150-4_11","volume":"165","author":"Kubuschok B","year":"2015","unstructured":"Kubuschok B, Held G, Pfreundschuh M. Management of diffuse large B-cell lymphoma (DLBCL). Cancer Treat Res, 2015, 165: 271-288.","journal-title":"Cancer Treat Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2217\/fon-2018-0788","volume":"15","author":"Morrison VA","year":"2019","unstructured":"Morrison VA, Shou Y, Bell JA, Hamilton L, Ogbonnaya A, Raju A, Hennenfent K. Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA. Future Oncol, 2019, 15: 1021-1034.","journal-title":"Future Oncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.clml.2017.10.007","volume":"17","author":"Cabanillas F","year":"2017","unstructured":"Cabanillas F, Shah B. Advances in diagnosis and management of diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk, 2017, 17: 783-796.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"null","first-page":"445","volume":"32","author":"Rutherford SC","year":"2018","unstructured":"Rutherford SC, Leonard JP. DLBCL cell of origin: what role should it play in care today?. Oncology (Williston Park), 2018, 32: 445-449.","journal-title":"Oncology (Williston Park)"},{"key":"null","doi-asserted-by":"crossref","first-page":"37417","DOI":"10.1038\/srep37417","volume":"6","author":"Kong Y","year":"2016","unstructured":"Kong Y, Chen G, Xu Z, Yang G, Li B, Wu X, Xiao W. Pterostilbene induces apoptosis and cell cycle arrest in diffuse large B-cell lymphoma cells. Sci Rep, 2016, 6:","journal-title":"Sci Rep"},{"key":"null","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/17474086.2017.1350164","volume":"10","author":"Chiappella A","year":"2017","unstructured":"Chiappella A, Santambrogio E, Castellino A, Nicolosi M, Vitolo U. Integrating novel drugs to chemoimmunotherapy in diffuse large B-cell lymphoma. Expert Rev Hematol, 2017, 10: 697-705.","journal-title":"Expert Rev Hematol"},{"key":"null","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1182\/blood-2015-09-672352","volume":"127","author":"Chapuy B","year":"2016","unstructured":"Chapuy B, Cheng H, Watahiki A, Ducar MD, Tan Y, Chen L, Roemer MG. Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease. Blood, 2016, 127: 2203-2213.","journal-title":"Blood"},{"key":"null","first-page":"669","volume":"58","author":"Karube K","year":"2017","unstructured":"Karube K. Genetic heterogeneity of DLBCL, not otherwise specified. Rinsho Ketsueki, 2017, 58: 669-675.","journal-title":"Rinsho Ketsueki"},{"key":"null","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000475530","volume":"85","author":"Schurch CM","year":"2018","unstructured":"Schurch CM, Federmann B, Quintanilla-Martinez L, Fend F. Tumor heterogeneity in lymphomas: a different breed. Pathobiology, 2018, 85: 130-145.","journal-title":"Pathobiology"},{"key":"null","first-page":"444","volume":"20","author":"Xiulan Z","year":"2001","unstructured":"Xiulan Z, Qiming Z, Li S, Ma H, Qin Z, Jiuhong K. Osalmide treats biliary tract diseases. Chin J New Drugs Clin Remedies, 2001, 20: 444-446.","journal-title":"Chin J New Drugs Clin Remedies"},{"key":"null","first-page":"8","volume":"14","author":"Kang JH","year":"1997","unstructured":"Kang JH, Zhang YL, Wang Q, Li J. Effects of gandanning on oxygen free radical and oxidative hemolysis of red blood cells. Chin J Mod Appl Pharm, 1997, 14: 8-10.","journal-title":"Chin J Mod Appl Pharm"},{"key":"null","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/carcin\/bgp121","volume":"30","author":"Pan MH","year":"2009","unstructured":"Pan MH, Chiou YS, Chen WJ, Wang JM, Badmaev V, Ho CT. Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Carcinogenesis, 2009, 30: 1234-1242.","journal-title":"Carcinogenesis"},{"key":"null","first-page":"9872073","volume":"2017","author":"Chang G","year":"2017","unstructured":"Chang G, Xiao W, Xu Z, Yu D, Li B, Zhang Y, Sun X. Pterostilbene induces cell apoptosis and cell cycle arrest in T-cell leukemia\/lymphoma by suppressing the ERK1\/2 pathway. Biomed Res Int, 2017, 2017:","journal-title":"Biomed Res Int"},{"key":"null","first-page":"575482","volume":"2013","author":"Denise M","year":"2013","unstructured":"Denise M, David M. A review of pterostilbene antioxidant activity and disease modification. Oxid Med Cell Longev, 2013, 2013:","journal-title":"Oxid Med Cell Longev"},{"key":"null","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/abbs\/gmz033","volume":"51","author":"Zhang T","year":"2019","unstructured":"Zhang T, Li B, Feng Q, Xu Z, Huang C, Wu H, Chen Z. DCZ0801, a novel compound, induces cell apoptosis and cell cycle arrest via MAPK pathway in multiple myeloma. Acta Biochim Biophys Sin, 2019, 51: 517-523.","journal-title":"Acta Biochim Biophys Sin"},{"key":"null","first-page":"1668","volume":"120","author":"Mary P","year":"2012","unstructured":"Mary P, Yue L, David O, Michael D, Elise VP, Joel S, Ignacio S. Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A. Blood, 2012, 120: 1668-1677.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2012-02-406074","volume":"120","author":"Pulvino M","year":"2012","unstructured":"Pulvino M, Liang Y, Oleksyn D, DeRan M, Van Pelt E, Shapiro J, Sanz I. Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A. Blood, 2012, 120: 1668-1677.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/030098589803500601","volume":"35","author":"Schafer KA","year":"1998","unstructured":"Schafer KA. The cell cycle: a review. Vet Pathol, 1998, 35: 461-478.","journal-title":"Vet Pathol"},{"key":"null","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"Marcos MMB","year":"2009","unstructured":"Marcos MMB. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer, 2009, 9: 153-166.","journal-title":"Nat Rev Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11060-017-2674-7","volume":"136","author":"Xu G","year":"2018","unstructured":"Xu G, Li JY. CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component. J Neurooncol, 2018, 136: 445-452.","journal-title":"J Neurooncol"},{"key":"null","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"Elmore S","year":"2007","unstructured":"Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol, 2007, 35: 495-516.","journal-title":"Toxicol Pathol"},{"key":"null","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.2147\/IJN.S140526","volume":"12","author":"Ou L","year":"2017","unstructured":"Ou L, Lin S, Song B, Liu J, Lai R, Shao L. The mechanisms of graphene-based materials-induced programmed cell death: a review of apoptosis, autophagy, and programmed necrosis. Int J Nanomedicine, 2017, 12: 6633-6646.","journal-title":"Int J Nanomedicine"},{"key":"null","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/cdd.2014.216","volume":"22","author":"Shalini S","year":"2015","unstructured":"Shalini S, Dorstyn L, Dawar S, Kumar S. Old, new and emerging functions of caspases. Cell Death Differ, 2015, 22: 526-539.","journal-title":"Cell Death Differ"},{"key":"null","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcdb.2017.11.036","volume":"82","author":"P\u00e9rez-Garijo A","year":"2018","unstructured":"P\u00e9rez-Garijo A. When dying is not the end: apoptotic caspases as drivers of proliferation. Semin Cell Dev Biol, 2018, 82: 86-95.","journal-title":"Semin Cell Dev Biol"},{"key":"null","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/mc.22752","volume":"57","author":"Slattery ML","year":"2018","unstructured":"Slattery ML, Mullany LE, Sakoda LC, Wolff RK, Stevens JR, Samowitz WS, Herrick JS. The PI3K\/AKT signaling pathway: associations of miRNAs with dysregulated gene expression in colorectal cancer. Mol Carcinog, 2018, 57: 243-261.","journal-title":"Mol Carcinog"},{"key":"null","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2016.01.012","volume":"109","author":"Asati V","year":"2016","unstructured":"Asati V, Mahapatra DK, Bharti SK. PI3K\/Akt\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives. Eur J Med Chem, 2016, 109: 314-341.","journal-title":"Eur J Med Chem"},{"key":"null","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1566524015666150114115427","volume":"15","author":"Dimitrova V","year":"2015","unstructured":"Dimitrova V, Arcaro A. Targeting the PI3K\/AKT\/mTOR signaling pathway in medulloblastoma. Curr Mol Med, 2015, 15: 82-93.","journal-title":"Curr Mol Med"},{"key":"null","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12031-016-0717-8","volume":"59","author":"Sun J","year":"2016","unstructured":"Sun J, Nan G. The mitogen-activated protein kinase (MAPK) signaling pathway as a discovery target in stroke. J Mol Neurosci, 2016, 59: 90-98.","journal-title":"J Mol Neurosci"},{"key":"null","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","volume":"35","author":"Sun Y","year":"2015","unstructured":"Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF. Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res, 2015, 35: 600-604.","journal-title":"J Recept Signal Transduct Res"},{"key":"null","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/MMBR.00043-14","volume":"80","author":"Zeke A","year":"2016","unstructured":"Zeke A, Misheva M, Remenyi A, Bogoyevitch MA. JNK signaling: regulation and functions based on complex protein-protein partnerships. Microbiol Mol Biol Rev, 2016, 80: 793-835.","journal-title":"Microbiol Mol Biol Rev"},{"key":"null","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"Cuadrado A","year":"2010","unstructured":"Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J, 2010, 429: 403-417.","journal-title":"Biochem J"},{"key":"null","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.bbadis.2018.08.024","volume":"1864","author":"Xu M","year":"2018","unstructured":"Xu M, Wang S, Wang Y, Wu H, Frank JA, Zhang Z, Luo J. Role of p38gamma MAPK in regulation of EMT and cancer stem cells. Biochim Biophys Acta Mol Basis Dis, 2018, 1864: 3605-3617.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"null","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"Wagner EF","year":"2009","unstructured":"Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer, 2009, 9: 537-549.","journal-title":"Nat Rev Cancer"},{"key":"null","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbrc.2015.05.042","volume":"463","author":"Liu J","year":"2015","unstructured":"Liu J, Chang F, Li F, Fu H, Wang J, Zhang S, Zhao J. Palmitate promotes autophagy and apoptosis through ROS-dependent JNK and p38 MAPK. Biochem Biophys Res Commun, 2015, 463: 262-267.","journal-title":"Biochem Biophys Res Commun"},{"key":"null","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/jee\/tox126","volume":"110","author":"Qiu L","year":"2017","unstructured":"Qiu L, Zhang B, Liu L, Wang X, Lei C, Lin Y, Zhao J. The role of p38 MAPK, JNK, and ERK in antibacterial responses of Chilo suppressalis (Lepidoptera: Crambidae). J Econ Entomol, 2017, 110: 1460-1464.","journal-title":"J Econ Entomol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/0B6301DCFC8547C6A839B7B7BAEDE30F","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmaa009","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/abbs\/article-pdf\/52\/4\/401\/33183041\/gmaa009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/0B6301DCFC8547C6A839B7B7BAEDE30F","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T08:51:57Z","timestamp":1665823917000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmaa009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,7]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmaa009","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}